LGI1 antibodies are involved in limbic encephalitis (over 90%) [36,37,38], but a small part of patients may develop epilepsy [39,40,41], a subacute encephalopathy, or Morvan syndrome [42,43]. Here, LGI1 is linked to epilepsy.